Literature DB >> 24199154

A hydrophobic site on the GLP-1 receptor extracellular domain orients the peptide ligand for signal transduction.

James T Patterson1, Pengyun Li, Jonathan W Day, Vasily M Gelfanov, Richard D Dimarchi.   

Abstract

Structure-function studies have analyzed substitutions within the glucagon-like peptide-1 (GLP-1) sequence that increase resistance to proteolysis, however, the investigation into how such substitutions alter interactions at the GLP-1 receptor (GLP-1R) has captured less attention. This work describes our efforts at identifying relevant interactions between peptide ligands and the GLP-1R extracellular domain that contribute to the positioning of the peptide N-terminus for receptor activation. Alanine substitutions at hydrophilic (Glu127⁎ and Glu128⁎) and hydrophobic (Leu32⁎) GLP-1R residues were previously shown to differentially interact with GLP-1 and exendin-4. We examined if these receptor residues influence the activity of GLP-1- and exendin-4-based peptides containing either alanine or glycine at position 2. Additionally, a series of glucagon-based peptides were studied to determine how the central to C-terminal region affects activity. Our results suggest that peptide binding to the GLP-1R is largely driven by hydrophobic interactions with the extracellular domain that orient the N-terminus for activation.

Entities:  

Keywords:  Exendin-4; GLP-1; GPCR; Glucagon; Receptor activation

Year:  2013        PMID: 24199154      PMCID: PMC3817388          DOI: 10.1016/j.molmet.2013.01.003

Source DB:  PubMed          Journal:  Mol Metab        ISSN: 2212-8778            Impact factor:   7.422


  33 in total

Review 1.  Activation of G-protein-coupled receptors: a common molecular mechanism.

Authors:  Sadashiva S Karnik; Camelia Gogonea; Supriya Patil; Yasser Saad; Takanobu Takezako
Journal:  Trends Endocrinol Metab       Date:  2003-11       Impact factor: 12.015

2.  Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor.

Authors:  Steve Bourgault; David Vaudry; Isabelle Ségalas-Milazzo; Laure Guilhaudis; Alain Couvineau; Marc Laburthe; Hubert Vaudry; Alain Fournier
Journal:  J Med Chem       Date:  2009-05-28       Impact factor: 7.446

3.  Full activation of chimeric receptors by hybrids between parathyroid hormone and calcitonin. Evidence for a common pattern of ligand-receptor interaction.

Authors:  C Bergwitz; T J Gardella; M R Flannery; J T Potts; H M Kronenberg; S R Goldring; H Jüppner
Journal:  J Biol Chem       Date:  1996-10-25       Impact factor: 5.157

4.  A novel human-based receptor antagonist of sustained action reveals body weight control by endogenous GLP-1.

Authors:  James T Patterson; Nickki Ottaway; Vasily M Gelfanov; David L Smiley; Diego Perez-Tilve; Paul T Pfluger; Matthias H Tschöp; Richard D Dimarchi
Journal:  ACS Chem Biol       Date:  2010-11-04       Impact factor: 5.100

5.  Importance of each residue within secretin for receptor binding and biological activity.

Authors:  Maoqing Dong; Angela Le; Jerez A Te; Delia I Pinon; Andrew J Bordner; Laurence J Miller
Journal:  Biochemistry       Date:  2011-03-21       Impact factor: 3.162

6.  Search for alpha-helical propensity in the receptor-bound conformation of glucagon-like peptide-1.

Authors:  Eunice N Murage; Jonathan C Schroeder; Martin Beinborn; Jung-Mo Ahn
Journal:  Bioorg Med Chem       Date:  2008-10-05       Impact factor: 3.641

7.  The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1.

Authors:  Rakel López de Maturana; Angela Willshaw; Antje Kuntzsch; Rainer Rudolph; Dan Donnelly
Journal:  J Biol Chem       Date:  2003-01-10       Impact factor: 5.157

8.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

Authors:  M J Perley; D M Kipnis
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

9.  Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.

Authors:  T J Kieffer; C H McIntosh; R A Pederson
Journal:  Endocrinology       Date:  1995-08       Impact factor: 4.736

10.  The third cytoplasmic domain of the GLP-1[7-36 amide] receptor is required for coupling to the adenylyl cyclase system.

Authors:  S Takhar; S Gyomorey; R C Su; S K Mathi; X Li; M B Wheeler
Journal:  Endocrinology       Date:  1996-05       Impact factor: 4.736

View more
  7 in total

1.  Molecular basis of peptide activation of the GLP-1 receptor.

Authors:  Laurence J Miller
Journal:  Mol Metab       Date:  2013-03-06       Impact factor: 7.422

Review 2.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

3.  Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators.

Authors:  Gaojie Song; Dehua Yang; Yuxia Wang; Chris de Graaf; Qingtong Zhou; Shanshan Jiang; Kaiwen Liu; Xiaoqing Cai; Antao Dai; Guangyao Lin; Dongsheng Liu; Fan Wu; Yiran Wu; Suwen Zhao; Li Ye; Gye Won Han; Jesper Lau; Beili Wu; Michael A Hanson; Zhi-Jie Liu; Ming-Wei Wang; Raymond C Stevens
Journal:  Nature       Date:  2017-05-17       Impact factor: 49.962

4.  Truncated Glucagon-like Peptide-1 and Exendin-4 α-Conotoxin pl14a Peptide Chimeras Maintain Potency and α-Helicity and Reveal Interactions Vital for cAMP Signaling in Vitro.

Authors:  Joakim E Swedberg; Christina I Schroeder; Justin M Mitchell; David P Fairlie; David J Edmonds; David A Griffith; Roger B Ruggeri; David R Derksen; Paula M Loria; David A Price; Spiros Liras; David J Craik
Journal:  J Biol Chem       Date:  2016-05-10       Impact factor: 5.157

5.  Structural Mapping and Functional Characterization of Zebrafish Class B G-Protein Coupled Receptor (GPCR) with Dual Ligand Selectivity towards GLP-1 and Glucagon.

Authors:  Deena A Oren; Yang Wei; Luce Skrabanek; Billy K C Chow; Thomas Mommsen; Svetlana Mojsov
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

Review 6.  The central GLP-1: implications for food and drug reward.

Authors:  Karolina P Skibicka
Journal:  Front Neurosci       Date:  2013-10-14       Impact factor: 4.677

7.  Inhibitory mechanism of an allosteric antibody targeting the glucagon receptor.

Authors:  Susmith Mukund; Yonglei Shang; Holly J Clarke; Azadeh Madjidi; Jacob E Corn; Lance Kates; Ganesh Kolumam; Vicky Chiang; Elizabeth Luis; Jeremy Murray; Yingnan Zhang; Isidro Hötzel; Christopher M Koth; Bernard B Allan
Journal:  J Biol Chem       Date:  2013-11-04       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.